Table of Contents
Key Points:
- The Saltzman family’s stake in Dis-Chem Pharmacies rose $13.68 million in the past 20 days due to share price gains.
- Dis-Chem Pharmacies shares increased by 3.02 percent, boosting the company’s market capitalization to more than $1.5 billion.
- Year-to-date, Dis-Chem Pharmacies shares have surged 10.10 percent, resulting in significant returns for investors.
The Saltzman family, renowned South African billionaires and founders of Dis-Chem Pharmacies have seen a substantial gain in the market value of their stake in recent weeks, driven by an increase in the group’s shares on the Johannesburg Stock Exchange (JSE).
According to market data tracked by Billionaire.Africa, the market value of the Saltzman family’s stake in Dis-Chem has risen by R249.55 million ($13.68 million) over the past 20 days.
This increase follows earlier gains recorded between April 24 and 30, when the market value of the family’s stake surged by R433.55 million ($23.05 million), climbing from R7.72 billion ($411.2 million) to R8.15 billion ($434.2 million).
Dis-Chem’s market cap surpasses $1.5 billion
Dis-Chem Pharmacies, a retail pharmacy chain and healthcare group based in South Africa, has evolved into one of the nation’s top retail healthcare groups since its inception over four decades ago by Lynette and Ivan Saltzman. The company offers a comprehensive array of services, including dispensaries, family clinics, wound care clinics, and extensive self-medication centers.
On the JSE, Dis-Chem’s share price has risen by 3.02 percent, from R32.79 ($1.798) on May 2 to R33.78 ($1.852) at the time of writing. This increase has pushed the company’s market cap above $1.5 billion, yielding substantial gains for its shareholders, including the Saltzman family.
Saltzmans’ Dis-Chem stake jumps $13.68 million
Lynette and Ivan Saltzman, who hold a significant 29.3-percent stake in the Gauteng-based healthcare group, have seen their holdings benefit handsomely from the recent upswing in the company’s shares.
The recent share price spike has caused the market value of their joint stake to increase by R249.55 million ($13.68 million), from R8.27 billion ($453.13 million) on May 2 to R8.51 billion ($466.81 million) at the time of drafting this report.
This significant increase in the market value of the Saltzman family’s stake in Dis-Chem further solidifies their position among South Africa’s wealthiest families, underscoring their enduring influence on the nation’s economic landscape.
Your Money and Your Life: Dis-Chem investors earn 10 percent YTD
Dis-Chem shares are among the many companies that have returned gains to investors since the start of the year.
Investors looking to emulate the wealth-building strategies of ultra-high-net-worth individuals by owning stakes in companies like the retail pharmacy chain and healthcare group have seen their fortunes surge this year.
Dis-Chem shares on the JSE have surged 10.07 percent year-to-date in 2024. This means a $100,000 investment in Eaton at the start of this year would be worth $110,070 at the time of writing, representing a gain of $10,070.
